
Thomas Josef Stegmann, Professor of Surgery, M.D., PhD
BACKGROUND
Studies of Human Medicine: Final Examination – 1974
Doctor Thesis (Dissertation): summa cum laude – 1974
Price of Faculty (University of Heidelberg) – 1974
Hannover Medical School (MHH) 1976 – present; Prof.Borst, Prof.Pichlmayr, Prof.Tscherne
Licenses: General Surgery – 1982, Cardiothoracic & Vascular Surgery – 1983
Rudolf-Nissen-Memorial-Award – 1982; Appointment Professor of Surgery – 1989
Head of the Dept. of Thoracic & Cardiovascular Surgery, Fulda Medical Center (1984-2006)
Faculty Member MHH (since 1982); Founder, CardioVascular BioTherapeutics, Inc. (1998)
Member – New York Academy of Sciences (since 2007); Member – Ukrainian Academy of Med. Sciences
Founder, CMO, Board-Member, CardioVascular Therapeutics, Inc., Las Vegas, NV, USA
CEO, Phage Pharmaceuticals, Inc., USA
OTHER INTERESTS
History
Sailing
RESEARCH
Angiogenic Therapy of Coronary Heart DiseaseAngiogenesis, MyogenesisAortic DissectionHeart & Lung TransplantationCoronary Bypass SurgeryAngiogenic Growth FactorsAbdominal Aortic Aneurysm – Surgical TreatmentSurgery of the Aorta
EDUCATION & TRAINING
Hannover Medical School (MHH), Germany
